Stephen Betz
Founder en CRINETICS PHARMACEUTICALS, INC. .
Fortuna: 4 M $ al 31/03/2024
Perfil
Stephen F.
Betz is the founder.
He founded Crinetics Pharmaceuticals, Inc. in 2008 and currently holds the title of Chief Scientific Officer.
He previously worked at Neurocrine Biosciences, Inc. from 2003 to 2009, where he held the position of Director-Endocrinology & Metabolism.
Before that, he worked at GeneFormatics, Inc. from 2001 to 2003 as the Head-Laboratory Efforts.
Mr. Betz completed his undergraduate degree at the University of Delaware in 1987.
He then went on to earn his doctorate degree from The University of North Carolina at Chapel Hill in 1993.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/03/2024 | 92 643 ( 0.12% ) | 4 M $ | 31/03/2024 |
Cargos activos de Stephen Betz
| Empresas | Cargo | Inicio |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Founder | 01/01/2008 |
Antiguos cargos conocidos de Stephen Betz.
| Empresas | Cargo | Fin |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/05/2009 |
| GeneFormatics, Inc. | Corporate Officer/Principal | 01/01/2003 |
Formación de Stephen Betz.
| University of Delaware | Undergraduate Degree |
| The University of North Carolina at Chapel Hill | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
| GeneFormatics, Inc. | Health Technology |
- Bolsa de valores
- Insiders
- Stephen Betz
